Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile.
about
Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic EventsPatient selection in heart failure with preserved ejection fraction clinical trialsINTERACTING DISCIPLINES: Cardiac natriuretic peptides and obesity: perspectives from an endocrinologist and a cardiologistN-terminal pro-brain natriuretic peptide and associated factors in the general working population: a baseline survey of the Uranosaki cohort study.The association between daily physical activity and plasma B-type natriuretic peptide in patients with glucose intolerance: a cross-sectional study.Gender-related alterations in plasma adrenomedullin level and its correlation with body weight gainN-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study.Higher BNP levels within physiological range correlate with beneficial nonfasting lipid profiles in the elderly: a cross-sectional studyChanges in N-terminal pro-B-type natriuretic peptide and incidence of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA)Brain Natriuretic Peptide in Liver Cirrhosis and Fatty Liver: Correlation with Cardiac Performance.Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study of AtherosclerosisPhenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.Serum Zn/Cu Ratio Is Associated with Renal Function, Glycemic Control, and Metabolic Parameters in Japanese Patients with and without Type 2 Diabetes: A Cross-sectional Study.Sex-Based Differences in Cardiometabolic Biomarkers.The multifaceted role of natriuretic peptides in metabolic syndrome.Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure.Associations of Proatrial Natriuretic Peptide with Components of the Metabolic Syndrome in Adolescents and Young Adults from the General Population.Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: The cardiovascular health study.Regional Fat Distribution and Blood Pressure Level and Variability: The Dallas Heart Study.A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA).Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial.Levels of N-terminal pro brain natriuretic peptide are enhanced in people with the uncomplicated metabolic syndrome: a case-cohort analysis of the population-based Casale Monferrato study.Natriuretic peptides in the control of lipid metabolism and insulin sensitivity.Maternal serum atrial natriuretic peptide (ANP) and brain-type natriuretic peptide (BNP) levels in gestational diabetes mellitus.The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study.The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure.Metabolomic profiling implicates adiponectin as mediator of a favorable lipoprotein profile associated with NT-proBNP
P2860
Q26778333-A57E9A19-5260-42AC-A1D9-D4342FE3F495Q27015845-F2CE56AE-678F-4EA1-8353-DBDBD683BCE3Q28083473-3DA2412C-1AE6-4C59-9BA6-F60D5BF32E50Q33918896-DCFC4880-2C54-4DCE-8BD4-DE7F68774968Q34981484-0E0D77C2-B71A-49C0-B223-86032EC71553Q35034900-534C8803-A2B8-4CBB-9D79-859DC48EF431Q36087146-77AFCA3A-D137-4CD1-BC1E-F976BF4C6601Q36428904-96688381-C1F6-4521-A242-1073576EDC23Q36697650-680F1AC6-8782-4B01-B1E6-FD991B24B334Q36766666-CBC8A212-DEE0-4D39-9B53-B3CD384F0F0FQ36806485-082FB83E-6D25-402F-A1EE-45AFD31F6ADBQ37058596-1A0C390C-FA07-4BB7-89E6-7D856E682EC5Q37413508-D3414967-6F4B-4F05-B61D-B58B7F86E68BQ38762587-723D4D28-C748-4E4D-9A16-C035D98ED60BQ39362608-0E936435-4A1E-4E1F-97B1-B08A423DDD77Q40000430-591B8CE0-9A57-4AFB-9535-09EC6E73CCFEQ40275959-13462C18-53C3-42C0-98A9-BF94FEFFF0EFQ40584596-DD42FC96-3CFA-478C-9415-D13CEBA6A4CCQ40644185-ECD9269F-A235-4C5B-A247-6B9A93E52D63Q47099891-8A64A02F-57EA-4733-BFA7-362AE6EEF026Q48240054-DDF121CA-118D-4634-A720-5AA7F8F7B370Q48465860-ACB90652-D03B-4034-877D-948DF280AE6EQ50122007-3DA63AEF-FB3D-4940-8A38-808280D62DC1Q51295918-E9294979-766E-4ED4-B9A7-2578AEE04945Q53756954-FFDB8BDB-AB87-45F6-8513-62A6A20563F2Q55025748-18AE11CF-B57F-4265-933A-79341DAEABF2Q57399030-6254091A-AD97-4788-9681-73D3B9A91262
P2860
Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Higher natriuretic peptide lev ...... e tissue distribution profile.
@en
Higher natriuretic peptide lev ...... e tissue distribution profile.
@nl
type
label
Higher natriuretic peptide lev ...... e tissue distribution profile.
@en
Higher natriuretic peptide lev ...... e tissue distribution profile.
@nl
prefLabel
Higher natriuretic peptide lev ...... e tissue distribution profile.
@en
Higher natriuretic peptide lev ...... e tissue distribution profile.
@nl
P2093
P2860
P1476
Higher natriuretic peptide lev ...... e tissue distribution profile.
@en
P2093
Alice Y Chang
Amit Khera
Aslan T Turer
Benjamin R Winders
Colby R Ayers
Darren K McGuire
Gloria L Vega
Ian J Neeland
James A de Lemos
Jarett D Berry
P2860
P304
P356
10.1016/J.JACC.2013.03.038
P407
P577
2013-04-16T00:00:00Z